· Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows
· Researchers invited to gain early access to platform and support ongoing product development
Constructive Bio is a growing Cambridge based biotechnology company built on a simple conviction: the molecules that matter most are often the ones that can’t yet be made.
We’ve rewritten the genetic code give cells access to new ncAA chemical building blocks - expanding the space of proteins that can be designed, engineered, and manufactured. Our platform moves from unexplored molecular territory to industrial-scale production, turning scientific possibility into manufacturable reality.
About the Role
We are seeking a Celebrity Ambassador Manager (0.5 FTE) to join our Fundraising Communications and Engagement team in the Development and Communication directorate. They will be responsible for recruiting and stewarding celebrities and influencers as ambassadors for the ICR to support our fundraising, communications and advocacy work.
Looking at patent filing data from the European Patent Office and international PCT system, the report reveals an interesting shift. While filing growth has slowed since the Metaverse boom, XR innovation remains strong and is increasingly focused on practical applications and commercial deployment across industries including healthcare, telecoms, automotive, aviation and entertainment.
Some of the key findings include:
Hosted by the Babraham Institute, this event will focus on the theme of ‘Restoring cellular resilience and tissue repair in ageing'.
The purpose of the CamNTF is to promote interactions between scientists from academia and industry to accelerate opportunities for biotechnology research and development. The event is open to all researchers interested in new therapeutics in the Cambridge area.
Attendance is free, but advance registration is required.
Agenda
17:30-18:00 Welcome, refreshments and networking
SuperDielectrics (SD) is pioneering a breakthrough battery technology designed for the high-power markets of the future, supporting the global shift to electrification. Our water-based batteries deliver market-leading performance through a novel polymer separator, combined with zinc halide electroactive species and carbon-based porous electrodes.
To accelerate commercialisation, SD operates a fully integrated product development model - from advanced materials through to cells, modules and packs - underpinned by in-house battery management systems.
At Dr. Reddy's "Good Health Can't Wait"
By joining Dr. Reddy’s, you will contribute to making the breakthroughs of tomorrow a reality today! From making medicines more affordable to discovering innovative treatment options to satisfy unmet medical needs, we are dedicated to helping people lead longer and healthier lives. We are seeking dynamic and energetic individuals ready to inspire, ready to make a difference for their community and every community.
Bring more to life.
Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology?
At Abcam, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact.
You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life.
Progress happens together
About us
Qureight’s mission is to accelerate clinical trials and ensure breakthroughs in lung and heart disease reach patients without delay. Our AI-powered data and imaging curation platform enables the analysis of clinical imaging and other healthcare data, helping our customers bring treatments to market, faster.
Are you ready to harness in vitro display platforms to unlock the next generation of peptide therapeutics for patients? In this Senior Scientist role, you will apply your expertise in mRNA, phage, yeast, and ribosome display to discover and optimize recombinant peptides that can reshape treatment options and accelerate our pipeline.